The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of pralatrexate (P) plus oxaliplatin (O) in advanced esophago-gastric cancer (aEGC): survival analysis and pharmacogenetic correlates.
 
Usha Malhotra
Research Funding - Merrimack (Inst)
 
Araba Adjei
No Relationships to Disclose
 
Austin Miller
No Relationships to Disclose
 
Peter Walter Bushunow
No Relationships to Disclose
 
Peter Loud
No Relationships to Disclose
 
Saikrishna S. Yendamuri
No Relationships to Disclose
 
Melissa Robins
No Relationships to Disclose
 
Renuka V. Iyer
No Relationships to Disclose
 
Nikhil I. Khushalani
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; Provectus
Speakers' Bureau - Prometheus
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Threshold Pharmaceuticals (Inst)